Medical Devices Startups
6,372 companies tagged Medical Devices, with their investors and founders.
Powerful Medical develops AI-driven diagnostic solutions for cardiovascular disease detection, serving clinicians and hospitals globally. The company's PMcardio platform analyzes electrocardiograms to identify conditions like heart attacks and STEMI with clinical validation across 25+ studies and 150+ hospital deployments.
2 investors
ProtaGene provides molecular bioanalytical services for gene therapy development, specializing in biodistribution studies, transgene expression assessment, and vector shedding analysis to support preclinical safety evaluation and clinical development of viral vector-based therapies.
2 investors
Precigen is a biopharmaceutical company developing gene and cell therapies, including PAPZIMEOS (zopapogene imadenovec-drba), an FDA-approved immunotherapy for adults with recurrent respiratory papillomatosis. The company focuses on immuno-oncology and immunotherapy treatments delivered via subcutaneous injection.
2 investors
PreComb is a Swiss biotech company developing its proprietary 3DTwin technology, which combines automated drug testing on patient-derived tumor twins with AI-guided data analysis and response prediction. The technology is designed for use in the clinic to support evidence-based, personalized treatment decisions in oncology.
2 investors
Predictably Human is developing NoMore, an adaptive drug delivery device paired with a personalized digital companion, aimed at patients with mental health conditions, addiction, and other complex disorders. The system is intended to support an ecosystem of digital products and services around treatment.
2 investors
Preferred Homecare provides in-home clinical services and durable medical equipment (DME), including wheelchairs and hospital beds, along with related therapies and products. It serves patients receiving care at home through trained professionals and clinicians.
2 investors
PregnanTech develops a silicone medical device placed around the uterine cervix to help keep the cervix elongated, addressing preterm birth. The device is inserted by a physician as a short outpatient procedure.
2 investors
PreludeDx develops precision diagnostic tests for breast cancer to help physicians make informed treatment decisions and improve patient outcomes. The company serves oncologists, breast surgeons, and pathologists requiring molecular diagnostics for DCIS and other breast cancer subtypes.
2 investors
PreTel develops wearable uterine electromyography sensors and AI-powered analysis software to monitor uterine contractions during pregnancy, enabling early detection of preterm labor, assessment of false labor, and guided Pitocin dosing during labor induction for obstetric care providers. The system integrates fetal heart rate, maternal heart rate, and contraction monitoring for use in hospital labor-and-delivery departments and remote home monitoring.
2 investors
Prevenotics develops AI-based medical diagnostic software focused on gastrointestinal cancer, aimed at improving diagnostic accuracy and identifying pre-cancerous risks to support preventive diagnosis. Its technology targets high-risk groups and seeks to reduce unnecessary biopsies for upper-GI cancer.
2 investors
Primaa develops AI services for computational pathology, building deep learning models that support pathologists in cancer diagnosis. The company's technology assists medical professionals with digital pathology and diagnostic accuracy, with a focus on areas such as breast pathology.
2 investors
Prime Discoveries develops multiplex PCR diagnostic panels that detect pathogens and antimicrobial-resistance genes across areas such as respiratory infection, sepsis, gastrointestinal illness, STIs, tropical fevers, and biosurveillance. Its panels serve clinical diagnostics, hospital infection control, public-health surveillance, pharmaceutical QC, and biodefense applications.
2 investors
Pristyn Care operates a network of clinics across India offering various medical specialities including proctology, laparoscopy, gynaecology, ENT, urology, and other surgical and medical services. The company provides healthcare services to patients seeking specialized medical treatment at multiple clinic locations throughout the country.
2 investors
Proclaim manufactures a customized oral health device that uses water pulsation to clean teeth and gums; it partners with dental professionals to create personalized mouthpieces via 3D scanning for individual users.
2 investors
Protembis is a German medical device company developing the ProtEmbo Cerebral Protection System, an intra-aortic filter device inserted via the left radial artery that shields the brain from embolic debris during transcatheter aortic valve replacement (TAVR) and other left-sided heart procedures. The device aims to reduce the risk of stroke and cognitive decline for cardiac patients and is undergoing clinical investigation.
2 investors
Prothea Technologies develops fluorescence imaging and optical sensing technologies for respiratory medicine and oncology applications. The company creates medical devices and diagnostic platforms focused on advancing clinical validation and regulatory approval for respiratory and cancer care.
2 investors
ProVerum is a venture-backed medical device startup developing minimally invasive technologies to treat benign prostatic hyperplasia (BPH). Founded in 2016, it is headquartered in Dublin, Ireland with a manufacturing facility in Galway and team members in the USA.
2 investors
Psygen is a licensed manufacturer of pharmaceutical-grade psychedelic active pharmaceutical ingredients for academic research, clinical trials, and authorized medical use. The company serves researchers, physicians, and healthcare systems working within regulated compassionate-use and special access programs.
2 investors
PTM Therapeutics is a biotechnology company developing therapeutic candidates. The page does not provide sufficient detail about the company's specific focus areas or customer markets.
2 investors
Pulsatile Innovations develops Pulse Tile, a medical device focused on emergency cardiac care, particularly cardiac arrest. The company pursues TGA compliance and a Class IIb regulatory pathway for its healthcare technology in Australia.
2 investors
PulseSight Therapeutics develops non-viral, plasmid-based gene therapies delivered via a proprietary electro-transfection system into the ciliary muscle to treat severe retinal diseases causing blindness. Its lead programs target late-stage dry AMD/geographic atrophy and wet AMD, with prior Phase 1/2 studies conducted in Europe and the USA.
2 investors
Purespring develops genetic therapies targeting podocytes to treat renal diseases through its proprietary GlomThera platform. The company focuses on preserving kidney function in patients with large, underserved populations affected by renal disease.
2 investors
Pykus Therapeutics is a clinical-stage medical technology company developing biodegradable polymers for vitreoretinal surgery. Its lead product, PYK-2101, is a biodegradable hydrogel intended to help patients recover from retina surgery faster and more comfortably.
2 investors
Qoniq provides data analysis and knowledge synthesis tools for Medical and Scientific Affairs professionals, helping them work with complex scientific datasets while augmenting rather than replacing human expertise.
2 investors